Regulatory feedback loop between TP73 and TRIM32

Cell Death and Disease

Volumn 4, Issue 7, 2013, Pages

  Gonzalez Cano, L ^a   Hillje, A L ^b,c   Fuertes Alvarez, S ^a   Marques, M M ^a   Blanch, A ^d   Ian, R W ^d   Irwin, M S ^d   Schwamborn, J C ^b,c   Marin M C ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

E3 ligase; Neural differentiation; P73; Transactivation; TRIM32; Ubiquitination

Indexed keywords

PROTEIN; PROTEIN TP73; PROTEIN TRIM32; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; EMBRYO; FEEDBACK SYSTEM; GENETIC TRANSCRIPTION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

EID: 84881054334     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.224     Document Type: Article

References (49)

1. Flores ER, Sengupta S, Miller JB, Newman JJ, Bronson R, Crowley D et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer cell 2005; 7: 363-373.
2. Lin Y, Cheng Z, Yang Z, Zheng J, Lin T. DNp73 improves generation efficiency of human induced pluripotent stem cells. BMC Cell Biol 2012; 13: 9.
3. De Laurenzi V, Raschella G, Barcaroli D, Annicchiarico-Petruzzelli M, Ranalli M, Catani MV et al. Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem 2000; 275: 15226-15231.
4. Fang L, Lee SW, Aaronson SA. Comparative analysis of p73 and p53 regulation and effector functions. J Cell Biol 1999; 147: 823-830.
5. Jost CA, Marin MC, Kaelin WG Jr. P73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997; 389: 191-194.
6. Jung MS, Yun J, Chae HD, Kim JM, Kim SC, Choi TS et al. P53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 2001; 20: 5818-5825.
7. Marques-Garcia F, Ferrandiz N, Fernandez-Alonso R, Gonzalez-Cano L, Herreros-Villanueva M, Rosa-Garrido M et al. P73 plays a role in erythroid differentiation through GATA1 induction. J Biol Chem 2009; 284: 21139-21156.
8. Ishimoto O, Kawahara C, Enjo K, Obinata M, Nukiwa T, Ikawa S. Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res 2002; 62: 636-641.
9. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M et al. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 2002; 196: 765-780.
10. Jacobs WB, Kaplan DR, Miller FD. The p53 family in nervous system development and disease. J Neurochem 2006; 97: 1571-1584.
11. Liu G, Nozell S, Xiao H, Chen X. DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol 2004; 24: 487-501.
12. Morgunkova AA. The p53 gene family: control of cell proliferation and developmental programs. Biochemistry Biokhimiia 2005; 70: 955-971.
13. Peschiaroli A, Scialpi F, Bernassola F, Pagano M, Melino G. The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene 2009; 28: 3157-3166.
14. Sayan BS, Yang AL, Conforti F, Tucci P, Piro MC, Browne GJ et al. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2. Proc Natl Acad Sci USA 2010; 107: 12877-12882.
15. Wu H, Zeinab RA, Flores ER, Leng RP. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination. Mol Cancer Res 2011; 9: 1780-1790.
16. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008; 22: 2677-2691.
17. Fernandez-Garcia B, Vaque JP, Herreros-Villanueva M, Marques-Garcia F, Castrillo F, Fernandez-Medarde A et al. P73 cooperates with Ras in the activation of MAP kinase signaling cascade. Cell Death Differ 2007; 14: 254-265.
18. Billon N, Terrinoni A, Jolicoeur C, McCarthy A, Richardson WD, Melino G et al. Roles for p53 and p73 during oligodendrocyte development. Development 2004; 131: 1211-1220.
19. Agostini M, Tucci P, Chen H, Knight RA, Bano D, Nicotera P et al. P73 regulates maintenance of neural stem cell. Biochem Biophys Res Commun 2010; 403: 13-17.
20. Fujitani M, Cancino GI, Dugani CB, Weaver IC, Gauthier-Fisher A, Paquin A et al. TAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors. Curr Biol 2010; 20: 2058-2065.
21. Gonzalez-Cano L, Herreros-Villanueva M, Fernandez-Alonso R, Ayuso-Sacido A, Meyer G, Garcia-Verdugo JM et al. P73 deficiency results in impaired self renewal and premature neuronal differentiation of mouse neural progenitors independently of p53. Cell Death Dis 2010; 1: e109.
22. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010; 5: e10615.
23. Rosenbluth JM, Pietenpol JA. The jury is in: p73 is a tumor suppressor after all. Genes Dev 2008; 22: 2591-2595.
24. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140-2151.
25. Hillje AL, Worlitzer MM, Palm T, Schwamborn JC. Neural stem cells maintain their stemness through protein kinase C zeta-mediated inhibition of TRIM32. Stem Cells 2011; 29: 1437-1447.
26. Schwamborn JC, Berezikov E, Knoblich JA. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 2009; 136: 913-925.
27. Nicklas S, Otto A, Wu X, Miller P, Stelzer S, Wen Y et al. TRIM32 regulates skeletal muscle stem cell differentiation and is necessary for normal adult muscle regeneration. PLoS One 2012; 7: e30445.
28. Sato T, Okumura F, Iguchi A, Ariga T, Hatakeyama S. TRIM32 promotes retinoic acid receptor alpha-mediated differentiation in human promyelogenous leukemic cell line HL60. Biochem Biophys Res Commun 2012; 417: 594-600.
29. Albor A, Kulesz-Martin M. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival. Mol Carcinogen 2007; 46: 585-590.
30. Kano S,Miyajima N, Fukuda S, Hatakeyama S. Tripartite motif protein 32 facilitates cell growth and migration via degradation of Abl-interactor 2. Cancer Res 2008; 68: 5572-5580.
31. Hammell CM, Lubin I, Boag PR, Blackwell TK, Ambros V. Nhl-2 modulates microRNA activity in Caenorhabditis elegans. Cell 2009; 136: 926-938.
32. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, Cepko CL. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992; 68: 33-51.
33. Reynolds BA, Weiss S. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996; 175: 1-13.
34. Sbisa E, Catalano D, Grillo G, Licciulli F, Turi A, Liuni S et al. P53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data. BMC Bioinform 2007; 8(Suppl 1): S20.
35. Horn EJ, Albor A, Liu Y, El-Hizawi S, Vanderbeek GE, Babcock M et al. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 2004; 25: 157-167.
36. Killick R, Niklison-Chirou M, Tomasini R, Bano D, Rufini A, Grespi F et al. P73: a multifunctional protein in neurobiology. Mol Neurobiol 2011; 43: 139-146.
37. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D et al. MicroRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci USA 2011; 108: 21099-21104.
38. De Laurenzi V, Rossi A, Terrinoni A, Barcaroli D, Levrero M, Costanzo A et al. P63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun 2000; 273: 342-346.
39. Talos F, Abraham A, Vaseva AV, Holembowski L, Tsirka SE, Scheel A et al. P73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death Differ 2010; 17: 1816-1829.
40. Wu L, Zhu H, Nie L, Maki CG. A link between p73 transcriptional activity and p73 degradation. Oncogene 2004; 23: 4032-4036.
41. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J et al. P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000; 404: 99-103.
42. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr. Butel JS et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-221.
43. Vicario-Abejon C, Yusta-Boyo MJ, Fernandez-Moreno C, de Pablo F. Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. J Neurosci 2003; 23: 895-906.
44. Armesilla-Diaz A, Bragado P, Del Valle I, Cuevas E, Lazaro I, Martin C et al. P53 regulates the self-renewal and differentiation of neural precursors. Neuroscience 2009; 158: 1378-1389.
45. Kudryashova E, Wu J, Havton LA, Spencer MJ. Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component. Hum Mol Genet 2009; 18: 1353-1367.
46. Watson IR, Irwin MS. Ubiquitin and ubiquitin-like modifications of the p53 family. Neoplasia 2006; 8: 655-666.
47. Marin MC, Jost CA, Irwin MS, DeCaprio JA, Caput D, Kaelin WG Jr. Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol 1998; 18: 6316-6324.
48. Watson IR, Blanch A, Lin DC, Ohh M, Irwin MS. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function. J Biol Chem 2006; 281: 34096-34103.
49. Lau LM, Nugent JK, Zhao X, Irwin MS. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 2008; 27: 997-1003.